US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mainz Biomed B.V.

1.45

-0.0500-3.33%

Volume:12.13K

Turnover:17.74K

Market Cap:7.85M

PE:-0.06

High:1.48

Open:1.48

Low:1.45

Close:1.50

52wk High:14.39

52wk Low:1.28

Shares:5.41M

Float Shares:4.64M

Volume Ratio:9.81

T/O Rate:0.26%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-22.3610

EPS(LYR):-22.3610

ROE:-465.82%

ROA:-114.35%

PB:3.11

PE(LYR):-0.06

Loading ...

Overview Company News Filings

Mainz Biomed NV to Attend Maxim Growth Summit in New York City

Mainz Biomed NV Reports Positive Results for BloodBased Pancreatic Cancer Screening Test in Feasibility Study

Mainz Biomed NV Enters Equity Distribution Agreement for Up to $10 Million in Ordinary Share Sales, Including $2.3 Million via Shelf Registration Statement

Mainz Biomed NV to Showcase Future of Colorectal Cancer Screening at World Endoscopy Organization Committee Meeting

Mainz Biomed Reports Financial Results for First Half of 2025

Mainz Biomed announces commercial launch of ColoAlert in Switzerland

Mainz Biomed NV Announces Launch of ColoAlert® in Switzerland and Advances in eAArly DETECT 2 Study

Mainz Biomed NV expected to post a loss of $2.80 a share - Earnings Preview

Mainz Biomed Announces Regulatory Approval of ColoAlert for Distribution in the United Kingdom

Mainz Biomed NV Receives Swissmedic Approval for ColoAlert® Cancer Screening Test in Switzerland

Mainz Biomed Prices $3 million Follow-on Offering at $1.35 per Unit

MT Newswires Live

Mainz Biomed NV Announces $3.0 Million Follow-On Offering of Ordinary Shares and Warrants

Mainz Biomed NV Files For Offering 1.5 Million Ordinary Units - SEC Filing

Mainz Biomed NV and CARE Partner to Enhance Colorectal Cancer Screening for German Health Insurers

Mainz Biomed NV Secures Government Funding for Innovative Pancreatic Cancer Screening Project from Rheinland-Pfalz Development Bank

Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition

Press Release: Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test

Mainz Biomed NV Board Meeting: Key Resolutions Include Amendment of Remuneration Policy and Auditor Assignments for 2025

Will AI Empower the PR Industry or Create Endless Seas of Spam? -- WSJ

Mainz Biomed NV Announces $4.0 Million Follow-On Offering with New Warrants Pricing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MYNZ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MYNZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MYNZ\",,,,,undefined,":{"symbol":"MYNZ","market":"US","secType":"STK","nameCN":"Mainz Biomed B.V.","latestPrice":1.45,"timestamp":1761917607206,"preClose":1.5,"halted":0,"volume":12131,"delay":0,"floatShares":4638500,"shares":5412900,"eps":-22.360981,"marketStatus":"Trading","change":-0.05,"latestTime":"10-31 09:33:30 EDT","open":1.48,"high":1.48,"low":1.45,"amount":17735.1059067,"amplitude":0.02,"askPrice":1.47,"askSize":400,"bidPrice":1.45,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-22.360981,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1761940800000},"marketStatusCode":2,"adr":0,"listingDate":1635998400000,"exchange":"NASDAQ","adjPreClose":1.5,"preHourTrading":{"tag":"盘前","latestPrice":1.4618,"preClose":1.5,"latestTime":"09:03 EDT","volume":10251,"amount":14873.8698927,"timestamp":1761915796459},"postHourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.5,"latestTime":"18:22 EDT","volume":171,"amount":250.4,"timestamp":1761862944219},"volumeRatio":9.807579},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MYNZ\",,,,,undefined,":{"symbol":"MYNZ","floatShares":4638500,"roa":"-114.35%","roe":"-465.82%","lyrEps":-22.360981,"volumeRatio":9.807579,"shares":5412900,"dividePrice":0,"high":1.48,"amplitude":0.02,"preClose":1.5,"low":1.45,"week52Low":1.2801,"pbRate":"3.11","psRate":"11.89","week52High":14.388,"institutionHeld":0,"latestPrice":1.45,"committee":0.111111,"eps":-22.360981,"divideRate":0,"volume":12131,"delay":0,"ttmEps":-22.360981,"open":1.48,"prevYearClose":4.32,"prevWeekClose":1.59,"prevMonthClose":1.49,"prevQuarterClose":1.49,"fiveDayClose":1.59,"twentyDayClose":1.73,"sixtyDayClose":1.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYNZ\",params:#limit:5,,,undefined,":[{"date":"2025-09-26","symbol":"MYNZ","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1758916800000,"name":null,"time":"Post Market","dateTimestamp":1758859200000,"actualEps":null},{"date":"2025-09-08","symbol":"MYNZ","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1757318400000,"name":null,"time":"Pre-Market","dateTimestamp":1757304000000,"actualEps":null},{"date":"2025-04-01","symbol":"MYNZ","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743494400000,"name":null,"time":"Pre-Market","dateTimestamp":1743480000000,"actualEps":null},{"market":"US","date":"2024-12-03","symbol":"MYNZ","defaultRemindTime":1733236200000,"type":"split","dateTimestamp":1733202000000,"forFactor":40,"toFactor":1,"ratio":40},{"date":"2024-10-18","symbol":"MYNZ","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1729281600000,"name":null,"time":"Post Market","dateTimestamp":1729224000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYNZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MYNZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1739592000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MYNZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MYNZ","date":"2025-10-30","current":-0.066187,"percent":0.75,"low":-348.357855,"twenty":-11.041709,"median":-1.579685,"eighty":-0.327897,"high":-0.107431,"avg":-25.150912,"sd":61.721266,"marketCap":7902765},"quantilePoints":[{"date":"2021-11-05","current":-122.23217,"twenty":-85.599226,"median":-61.177263,"eighty":-61.177263,"marketCap":116982909},{"date":"2021-11-12","current":-125.489141,"twenty":-123.534958,"median":-114.320607,"eighty":-61.177263,"marketCap":120100010},{"date":"2021-11-19","current":-122.979358,"twenty":-129.554989,"median":-122.605764,"eighty":-89.223302,"marketCap":117698009},{"date":"2021-11-26","current":-123.606803,"twenty":-128.350293,"median":-123.293081,"eighty":-110.480639,"marketCap":118298509},{"date":"2021-12-03","current":-101.897183,"twenty":-127.371478,"median":-122.23217,"eighty":-108.673596,"marketCap":97521208},{"date":"2021-12-10","current":-124.610716,"twenty":-126.618543,"median":-121.975445,"eighty":-104.908922,"marketCap":119259309},{"date":"2021-12-17","current":-113.567673,"twenty":-125.489141,"median":-117.834303,"eighty":-107.920661,"marketCap":108690509},{"date":"2021-12-23","current":-131.010663,"twenty":-125.489141,"median":-117.834303,"eighty":-108.297128,"marketCap":125384410},{"date":"2021-12-31","current":-130.383217,"twenty":-130.107141,"median":-120.469575,"eighty":-110.028878,"marketCap":124783910},{"date":"2022-01-07","current":-174.429905,"twenty":-130.885174,"median":-122.23217,"eighty":-111.007693,"marketCap":166939013},{"date":"2022-01-14","current":-261.895816,"twenty":-135.703956,"median":-123.293081,"eighty":-111.50965,"marketCap":250648700},{"date":"2022-01-21","current":-348.357855,"twenty":-171.543655,"median":-125.049928,"eighty":-112.31278,"marketCap":333397627},{"date":"2022-01-28","current":-223.162984,"twenty":-190.868983,"median":-127.371478,"eighty":-112.940227,"marketCap":213579250},{"date":"2022-02-04","current":-202.927627,"twenty":-202.927627,"median":-129.693027,"eighty":-113.567673,"marketCap":194212900},{"date":"2022-02-11","current":-218.283536,"twenty":-204.685221,"median":-130.383217,"eighty":-114.320607,"marketCap":208909350},{"date":"2022-02-18","current":-227.755406,"twenty":-215.554712,"median":-131.700853,"eighty":-114.822564,"marketCap":217974450},{"date":"2022-02-25","current":-212.686523,"twenty":-213.260161,"median":-133.959657,"eighty":-115.424912,"marketCap":203552700},{"date":"2022-03-04","current":-177.095256,"twenty":-211.538417,"median":-137.912565,"eighty":-117.18176,"marketCap":169489900},{"date":"2022-03-11","current":-198.765745,"twenty":-211.251391,"median":-160.160702,"eighty":-117.784107,"marketCap":190229750},{"date":"2022-03-18","current":-221.297313,"twenty":-211.538417,"median":-174.429905,"eighty":-118.737825,"marketCap":211793700},{"date":"2022-03-25","current":-208.95518,"twenty":-215.21194,"median":-179.527255,"eighty":-119.164488,"marketCap":199981600},{"date":"2022-04-01","current":-219.144616,"twenty":-215.69864,"median":-184.98848,"eighty":-121.22251,"marketCap":209733450},{"date":"2022-04-08","current":-207.663562,"twenty":-215.700299,"median":-190.224942,"eighty":-122.126032,"marketCap":198745450},{"date":"2022-04-14","current":-203.216088,"twenty":-215.555542,"median":-192.020626,"eighty":-122.229871,"marketCap":194488973},{"date":"2022-04-22","current":-184.414428,"twenty":-215.297633,"median":-192.164139,"eighty":-122.529895,"marketCap":176494750},{"date":"2022-04-29","current":-178.530387,"twenty":-214.867923,"median":-191.157778,"eighty":-122.878966,"marketCap":170863400},{"date":"2022-05-06","current":-14.569419,"twenty":-213.490197,"median":-189.580902,"eighty":-122.02564,"marketCap":170317941},{"date":"2022-05-13","current":-13.40506,"twenty":-212.686523,"median":-185.993072,"eighty":-117.733912,"marketCap":156706466},{"date":"2022-05-20","current":-14.62913,"twenty":-211.825444,"median":-184.414428,"eighty":-114.019433,"marketCap":171015965},{"date":"2022-05-27","current":-14.163386,"twenty":-211.251391,"median":-182.182249,"eighty":-111.15828,"marketCap":165571375},{"date":"2022-06-03","current":-13.542395,"twenty":-210.734743,"median":-179.176197,"eighty":-107.920661,"marketCap":158311922},{"date":"2022-06-10","current":-13.088593,"twenty":-209.844962,"median":-176.8142,"eighty":-77.113861,"marketCap":153006937},{"date":"2022-06-17","current":-10.729422,"twenty":-209.557936,"median":-167.717849,"eighty":-15.656155,"marketCap":125427995},{"date":"2022-06-24","current":-12.085453,"twenty":-209.357017,"median":-151.625827,"eighty":-14.581361,"marketCap":141280128},{"date":"2022-07-01","current":-11.225618,"twenty":-209.184802,"median":-135.77925,"eighty":-14.175328,"marketCap":131228577},{"date":"2022-07-08","current":-12.473573,"twenty":-208.95518,"median":-132.516532,"eighty":-13.817064,"marketCap":145817286},{"date":"2022-07-15","current":-11.225618,"twenty":-207.663562,"median":-130.69694,"eighty":-13.542395,"marketCap":131228577},{"date":"2022-07-22","current":-11.989916,"twenty":-207.520048,"median":-130.383217,"eighty":-13.387147,"marketCap":140163289},{"date":"2022-07-29","current":-11.28521,"twenty":-207.376535,"median":-128.187158,"eighty":-13.136362,"marketCap":131925206},{"date":"2022-08-05","current":-11.703304,"twenty":-206.658969,"median":-125.489141,"eighty":-12.993056,"marketCap":136812772},{"date":"2022-08-12","current":-10.962891,"twenty":-206.304148,"median":-124.108759,"eighty":-12.360122,"marketCap":128157270},{"date":"2022-08-19","current":-11.058428,"twenty":-205.79789,"median":-122.728379,"eighty":-12.085453,"marketCap":129274109},{"date":"2022-08-26","current":-10.222478,"twenty":-205.510864,"median":-121.975445,"eighty":-11.930205,"marketCap":119501768},{"date":"2022-09-02","current":-10.497147,"twenty":-204.685221,"median":-118.963705,"eighty":-11.786899,"marketCap":122712680},{"date":"2022-09-09","current":-5.448256,"twenty":-204.542062,"median":-117.583325,"eighty":-11.703973,"marketCap":130926084},{"date":"2022-09-16","current":-5.36388,"twenty":-204.16184,"median":-114.571585,"eighty":-11.622097,"marketCap":128898468},{"date":"2022-09-23","current":-4.158514,"twenty":-203.388017,"median":-112.940227,"eighty":-11.454907,"marketCap":99932520},{"date":"2022-09-30","current":-4.1555,"twenty":-202.985319,"median":-111.120633,"eighty":-11.313966,"marketCap":99860098},{"date":"2022-10-07","current":-3.833065,"twenty":-202.416321,"median":-107.920661,"eighty":-11.201734,"marketCap":92111708},{"date":"2022-10-14","current":-4.224809,"twenty":-201.881317,"median":-102.399139,"eighty":-11.07037,"marketCap":101525640},{"date":"2022-10-21","current":-4.092219,"twenty":-201.205469,"median":-61.177263,"eighty":-11.020213,"marketCap":98339386},{"date":"2022-10-28","current":-4.200702,"twenty":-200.947146,"median":-38.739147,"eighty":-10.888849,"marketCap":100946321},{"date":"2022-11-04","current":-4.242889,"twenty":-200.918443,"median":-14.688841,"eighty":-10.635963,"marketCap":101960129},{"date":"2022-11-11","current":-4.538204,"twenty":-200.918443,"median":-14.473882,"eighty":-10.494759,"marketCap":109056786},{"date":"2022-11-18","current":-5.650155,"twenty":-199.196285,"median":-14.223097,"eighty":-9.260245,"marketCap":135777871},{"date":"2022-11-25","current":-5.273478,"twenty":-197.388018,"median":-13.888717,"eighty":-5.530221,"marketCap":126726013},{"date":"2022-12-02","current":-4.98419,"twenty":-196.038994,"median":-13.805122,"eighty":-5.421702,"marketCap":119774186},{"date":"2022-12-09","current":-4.761197,"twenty":-195.493645,"median":-13.733469,"eighty":-5.347005,"marketCap":114415486},{"date":"2022-12-16","current":-4.266997,"twenty":-194.632565,"median":-13.476713,"eighty":-5.266559,"marketCap":102539448},{"date":"2022-12-23","current":-4.321238,"twenty":-193.312244,"median":-13.387147,"eighty":-5.154147,"marketCap":103842916},{"date":"2022-12-30","current":-4.282005,"twenty":-192.508571,"median":-13.255783,"eighty":-4.986601,"marketCap":102900108},{"date":"2023-01-06","current":-3.781433,"twenty":-192.106734,"median":-13.136362,"eighty":-4.907046,"marketCap":90870940},{"date":"2023-01-13","current":-3.992517,"twenty":-191.791005,"median":-13.094564,"eighty":-4.722625,"marketCap":95943481},{"date":"2023-01-20","current":-4.221695,"twenty":-191.446573,"median":-12.9632,"eighty":-4.700929,"marketCap":101450811},{"date":"2023-01-27","current":-3.956331,"twenty":-190.868983,"median":-12.706444,"eighty":-4.520124,"marketCap":95073902},{"date":"2023-02-03","current":-4.155354,"twenty":-189.724415,"median":-12.324295,"eighty":-4.369453,"marketCap":99856583},{"date":"2023-02-10","current":-3.980455,"twenty":-189.580902,"median":-12.085453,"eighty":-4.339319,"marketCap":95653621},{"date":"2023-02-17","current":-4.192143,"twenty":-186.997665,"median":-11.960061,"eighty":-4.282005,"marketCap":100740655},{"date":"2023-02-24","current":-4.095044,"twenty":-186.882855,"median":-11.90035,"eighty":-4.277845,"marketCap":98407286},{"date":"2023-03-03","current":-4.19154,"twenty":-185.476425,"median":-11.822726,"eighty":-4.263968,"marketCap":100726162},{"date":"2023-03-10","current":-3.992517,"twenty":-185.017183,"median":-11.780928,"eighty":-4.24289,"marketCap":95943481},{"date":"2023-03-17","current":-3.980455,"twenty":-184.529238,"median":-11.703304,"eighty":-4.233757,"marketCap":95653621},{"date":"2023-03-24","current":-3.817619,"twenty":-184.069996,"median":-11.65255,"eighty":-4.221112,"marketCap":91740519},{"date":"2023-03-31","current":-3.787464,"twenty":-182.720972,"median":-11.488345,"eighty":-4.218158,"marketCap":91015870},{"date":"2023-04-06","current":-3.82968,"twenty":-182.13765,"median":-11.464461,"eighty":-4.205478,"marketCap":92030378},{"date":"2023-04-14","current":-3.292638,"twenty":-180.676905,"median":-11.40475,"eighty":-4.193662,"marketCap":86883946},{"date":"2023-04-21","current":-2.472288,"twenty":-179.047035,"median":-11.28521,"eighty":-4.177331,"marketCap":65237092},{"date":"2023-04-28","current":-2.247534,"twenty":-177.669308,"median":-11.225618,"eighty":-4.160237,"marketCap":59306448},{"date":"2023-05-05","current":-2.736373,"twenty":-176.926622,"median":-11.094255,"eighty":-4.134849,"marketCap":72205600},{"date":"2023-05-12","current":-2.949889,"twenty":-175.383623,"median":-11.07037,"eighty":-4.123558,"marketCap":77839713},{"date":"2023-05-19","current":-2.904938,"twenty":-172.698155,"median":-11.046486,"eighty":-4.101075,"marketCap":76653584},{"date":"2023-05-26","current":-2.809417,"twenty":-166.952688,"median":-10.95692,"eighty":-4.083699,"marketCap":76653584},{"date":"2023-06-02","current":-3.070959,"twenty":-160.90697,"median":-10.921094,"eighty":-4.043177,"marketCap":83789632},{"date":"2023-06-09","current":-2.717038,"twenty":-152.586533,"median":-10.831527,"eighty":-3.993826,"marketCap":74133060},{"date":"2023-06-16","current":-2.662697,"twenty":-143.258402,"median":-10.629228,"eighty":-3.981767,"marketCap":72650398},{"date":"2023-06-23","current":-2.450768,"twenty":-137.485902,"median":-10.613584,"eighty":-3.980455,"marketCap":66868020},{"date":"2023-06-30","current":-2.622229,"twenty":-135.77925,"median":-10.491176,"eighty":-3.980455,"marketCap":71546253},{"date":"2023-07-07","current":-2.578452,"twenty":-135.478076,"median":-10.353842,"eighty":-3.956331,"marketCap":70351802},{"date":"2023-07-14","current":-2.55603,"twenty":-133.093782,"median":-5.650155,"eighty":-3.892627,"marketCap":69740047},{"date":"2023-07-21","current":-2.578452,"twenty":-132.416141,"median":-5.526605,"eighty":-3.854481,"marketCap":70351802},{"date":"2023-07-28","current":-2.410292,"twenty":-131.286739,"median":-5.424148,"eighty":-3.799838,"marketCap":65763641},{"date":"2023-08-04","current":-2.242132,"twenty":-130.508706,"median":-5.409082,"eighty":-3.779021,"marketCap":61175480},{"date":"2023-08-11","current":-1.964668,"twenty":-130.383217,"median":-5.36388,"eighty":-3.748866,"marketCap":53605014},{"date":"2023-08-18","current":-1.601549,"twenty":-130.383217,"median":-5.286134,"eighty":-3.603922,"marketCap":45800356},{"date":"2023-08-25","current":-1.781929,"twenty":-130.383217,"median":-5.256181,"eighty":-3.297178,"marketCap":50958758},{"date":"2023-09-01","current":-1.672608,"twenty":-129.278913,"median":-5.177048,"eighty":-3.082493,"marketCap":47832454},{"date":"2023-09-08","current":-1.787395,"twenty":-128.024022,"median":-5.12582,"eighty":-3.020686,"marketCap":51115073},{"date":"2023-09-15","current":-2.159085,"twenty":-127.371478,"median":-4.98419,"eighty":-2.939347,"marketCap":61744507},{"date":"2023-09-22","current":-1.721802,"twenty":-126.618543,"median":-4.935975,"eighty":-2.904938,"marketCap":49239291},{"date":"2023-09-29","current":-1.797872,"twenty":-125.489141,"median":-4.776264,"eighty":-2.835944,"marketCap":51414702},{"date":"2023-10-06","current":-1.657322,"twenty":-125.137771,"median":-4.719009,"eighty":-2.790941,"marketCap":47395311},{"date":"2023-10-13","current":-1.376221,"twenty":-124.209151,"median":-4.703942,"eighty":-2.740468,"marketCap":39356531},{"date":"2023-10-20","current":-1.405503,"twenty":-123.355825,"median":-4.562312,"eighty":-2.722472,"marketCap":40193904},{"date":"2023-10-27","current":-1.194677,"twenty":-123.104847,"median":-4.538204,"eighty":-2.715951,"marketCap":34164818},{"date":"2023-11-03","current":-1.270809,"twenty":-122.778575,"median":-4.474922,"eighty":-2.700736,"marketCap":36341988},{"date":"2023-11-10","current":-1.528484,"twenty":-122.331412,"median":-4.369453,"eighty":-2.634201,"marketCap":43710870},{"date":"2023-11-17","current":-0.799024,"twenty":-122.227572,"median":-4.346848,"eighty":-2.605487,"marketCap":23412240},{"date":"2023-11-24","current":-0.771231,"twenty":-121.925249,"median":-4.330279,"eighty":-2.573923,"marketCap":22597901},{"date":"2023-12-01","current":-0.792076,"twenty":-120.218597,"median":-4.309185,"eighty":-2.553788,"marketCap":23208655},{"date":"2023-12-08","current":-0.785128,"twenty":-119.114292,"median":-4.282005,"eighty":-2.516303,"marketCap":23005071},{"date":"2023-12-14","current":-0.743439,"twenty":-118.737825,"median":-4.27905,"eighty":-2.481303,"marketCap":21783562},{"date":"2023-12-22","current":-0.819868,"twenty":-118.286064,"median":-4.275974,"eighty":-2.472153,"marketCap":24022994},{"date":"2023-12-29","current":-0.819868,"twenty":-117.784107,"median":-4.274499,"eighty":-2.453883,"marketCap":24022994},{"date":"2024-01-05","current":-0.743439,"twenty":-117.633521,"median":-4.266997,"eighty":-2.406929,"marketCap":21783562},{"date":"2024-01-12","current":-0.81292,"twenty":-115.977064,"median":-4.250383,"eighty":-2.301548,"marketCap":23819409},{"date":"2024-01-19","current":-0.743439,"twenty":-115.123738,"median":-4.24289,"eighty":-2.242046,"marketCap":21783562},{"date":"2024-01-26","current":-0.708699,"twenty":-114.52139,"median":-4.239788,"eighty":-2.151945,"marketCap":20765639},{"date":"2024-02-02","current":-0.660063,"twenty":-113.868847,"median":-4.229283,"eighty":-2.034522,"marketCap":19340546},{"date":"2024-02-09","current":-0.799024,"twenty":-113.191205,"median":-4.221695,"eighty":-1.940461,"marketCap":23412240},{"date":"2024-02-16","current":-0.694803,"twenty":-112.563759,"median":-4.218782,"eighty":-1.843655,"marketCap":20358470},{"date":"2024-02-23","current":-0.660966,"twenty":-111.911215,"median":-4.217223,"eighty":-1.826255,"marketCap":19367012},{"date":"2024-03-01","current":-0.614345,"twenty":-111.15828,"median":-4.206728,"eighty":-1.791586,"marketCap":18000959},{"date":"2024-03-08","current":-0.654366,"twenty":-110.480639,"median":-4.199136,"eighty":-1.767716,"marketCap":19173607},{"date":"2024-03-15","current":-0.708699,"twenty":-109.050063,"median":-4.192143,"eighty":-1.72412,"marketCap":20765639},{"date":"2024-03-22","current":-0.726556,"twenty":-107.920661,"median":-4.185509,"eighty":-1.710365,"marketCap":21288852},{"date":"2024-03-28","current":-0.687925,"twenty":-106.916748,"median":-4.164803,"eighty":-1.687376,"marketCap":20156921},{"date":"2024-04-05","current":-0.750387,"twenty":-102.700313,"median":-4.161385,"eighty":-1.668235,"marketCap":21987147},{"date":"2024-04-12","current":-0.778083,"twenty":-101.721498,"median":-4.155427,"eighty":-1.621576,"marketCap":20460262},{"date":"2024-04-19","current":-0.752421,"twenty":-93.05046,"median":-4.13123,"eighty":-1.597176,"marketCap":19785463},{"date":"2024-04-26","current":-0.713136,"twenty":-61.177263,"median":-4.129805,"eighty":-1.458209,"marketCap":18752417},{"date":"2024-05-03","current":-0.636812,"twenty":-61.177263,"median":-4.113137,"eighty":-1.405503,"marketCap":16745440},{"date":"2024-05-10","current":-0.548502,"twenty":-52.202017,"median":-4.101075,"eighty":-1.353967,"marketCap":14423252},{"date":"2024-05-17","current":-0.534352,"twenty":-16.086072,"median":-4.095044,"eighty":-1.223959,"marketCap":14051181},{"date":"2024-05-24","current":-0.468432,"twenty":-15.118759,"median":-4.066503,"eighty":-1.166567,"marketCap":12317764},{"date":"2024-05-31","current":-0.600938,"twenty":-14.688841,"median":-4.043781,"eighty":-0.836149,"marketCap":15802107},{"date":"2024-06-07","current":-0.64089,"twenty":-14.62913,"median":-4.022672,"eighty":-0.83029,"marketCap":16852662},{"date":"2024-06-14","current":-0.549334,"twenty":-14.581361,"median":-3.992517,"eighty":-0.819868,"marketCap":14445139},{"date":"2024-06-21","current":-0.466102,"twenty":-14.454775,"median":-3.986486,"eighty":-0.812922,"marketCap":12256482},{"date":"2024-06-28","current":-0.387946,"twenty":-14.378345,"median":-3.983736,"eighty":-0.81292,"marketCap":10201332},{"date":"2024-07-05","current":-0.278912,"twenty":-14.254147,"median":-3.980455,"eighty":-0.804582,"marketCap":7334191},{"date":"2024-07-12","current":-0.385699,"twenty":-14.223097,"median":-3.980455,"eighty":-0.799024,"marketCap":10142238},{"date":"2024-07-15","current":-0.397685,"twenty":-14.223097,"median":-3.980455,"eighty":-0.799024,"marketCap":10457405},{"date":"2024-08-02","current":-0.341253,"twenty":-14.211155,"median":-3.980455,"eighty":-0.794635,"marketCap":8973495},{"date":"2024-08-09","current":-0.273835,"twenty":-14.108452,"median":-3.980455,"eighty":-0.77957,"marketCap":7200683},{"date":"2024-08-16","current":-0.266344,"twenty":-13.876775,"median":-3.956331,"eighty":-0.771926,"marketCap":7003704},{"date":"2024-08-23","current":-0.288983,"twenty":-13.826618,"median":-3.908083,"eighty":-0.76472,"marketCap":7599018},{"date":"2024-08-30","current":-0.301718,"twenty":-13.812287,"median":-3.878489,"eighty":-0.757335,"marketCap":7933883},{"date":"2024-09-06","current":-0.277996,"twenty":-13.79318,"median":-3.865866,"eighty":-0.753254,"marketCap":7310116},{"date":"2024-09-13","current":-0.266677,"twenty":-13.740396,"median":-3.82968,"eighty":-0.750387,"marketCap":7012458},{"date":"2024-09-20","current":-0.207998,"twenty":-13.733469,"median":-3.795198,"eighty":-0.743439,"marketCap":5469455},{"date":"2024-09-27","current":-0.178034,"twenty":-13.542395,"median":-3.787464,"eighty":-0.743439,"marketCap":4681538},{"date":"2024-10-04","current":-0.213408,"twenty":-13.530453,"median":-3.764848,"eighty":-0.732362,"marketCap":5611717},{"date":"2024-10-11","current":-0.269507,"twenty":-13.422973,"median":-3.751278,"eighty":-0.723456,"marketCap":7086872},{"date":"2024-10-18","current":-0.248033,"twenty":-13.40506,"median":-3.674383,"eighty":-0.721625,"marketCap":6522199},{"date":"2024-10-25","current":-0.316154,"twenty":-13.387147,"median":-3.433109,"eighty":-0.715647,"marketCap":7115626},{"date":"2024-10-31","current":-0.289893,"twenty":-13.38237,"median":-3.33197,"eighty":-0.712249,"marketCap":6524576},{"date":"2024-11-08","current":-0.250104,"twenty":-13.280862,"median":-3.28421,"eighty":-0.708699,"marketCap":5629046},{"date":"2024-11-15","current":-0.284209,"twenty":-13.236676,"median":-3.084741,"eighty":-0.702634,"marketCap":6396643},{"date":"2024-11-22","current":-0.241464,"twenty":-13.155469,"median":-3.046946,"eighty":-0.700361,"marketCap":5434588},{"date":"2024-11-29","current":-0.250104,"twenty":-13.136362,"median":-3.006077,"eighty":-0.693519,"marketCap":5629046},{"date":"2024-12-06","current":-0.192978,"twenty":-13.114866,"median":-2.949889,"eighty":-0.679323,"marketCap":4343318},{"date":"2024-12-13","current":-0.159157,"twenty":-13.09337,"median":-2.910557,"eighty":-0.663987,"marketCap":3582118},{"date":"2024-12-20","current":-0.135568,"twenty":-13.031271,"median":-2.882463,"eighty":-0.653703,"marketCap":3051197},{"date":"2024-12-27","current":-0.129031,"twenty":-12.969172,"median":-2.842021,"eighty":-0.646445,"marketCap":2904074},{"date":"2025-01-03","current":-0.12221,"twenty":-12.914238,"median":-2.826275,"eighty":-0.637885,"marketCap":2750555},{"date":"2025-01-10","current":-0.354813,"twenty":-12.837808,"median":-2.803983,"eighty":-0.625879,"marketCap":7985713},{"date":"2025-01-17","current":-0.413503,"twenty":-12.706444,"median":-2.746611,"eighty":-0.61592,"marketCap":9306658},{"date":"2025-01-24","current":-0.392161,"twenty":-12.520147,"median":-2.741492,"eighty":-0.612705,"marketCap":8826315},{"date":"2025-01-31","current":-0.474862,"twenty":-12.382812,"median":-2.729795,"eighty":-0.600605,"marketCap":10687646},{"date":"2025-02-07","current":-0.64471,"twenty":-12.3028,"median":-2.719755,"eighty":-0.600605,"marketCap":14510382},{"date":"2025-02-14","current":-0.580683,"twenty":-12.154717,"median":-2.711604,"eighty":-0.600605,"marketCap":13069350},{"date":"2025-02-21","current":-0.497983,"twenty":-12.099783,"median":-2.700736,"eighty":-0.578131,"marketCap":11208019},{"date":"2025-02-28","current":-0.53711,"twenty":-12.035296,"median":-2.65047,"eighty":-0.562601,"marketCap":12088649},{"date":"2025-03-07","current":-0.484644,"twenty":-11.994693,"median":-2.628899,"eighty":-0.545724,"marketCap":10907804},{"date":"2025-03-14","current":-0.708013,"twenty":-11.954089,"median":-2.606478,"eighty":-0.53711,"marketCap":15935147},{"date":"2025-03-21","current":-0.718491,"twenty":-11.930205,"median":-2.578452,"eighty":-0.539778,"marketCap":16170974},{"date":"2025-03-28","current":-0.593953,"twenty":-11.894378,"median":-2.561579,"eighty":-0.545724,"marketCap":13368005},{"date":"2025-04-04","current":-0.518165,"twenty":-11.870494,"median":-2.55603,"eighty":-0.535637,"marketCap":11218613},{"date":"2025-04-11","current":-0.451954,"twenty":-11.841833,"median":-2.519102,"eighty":-0.52786,"marketCap":9785106},{"date":"2025-04-17","current":-0.449147,"twenty":-11.808395,"median":-2.507977,"eighty":-0.516142,"marketCap":9724329},{"date":"2025-04-25","current":-0.449147,"twenty":-11.786899,"median":-2.477938,"eighty":-0.500964,"marketCap":9724329},{"date":"2025-05-02","current":-0.418268,"twenty":-11.782122,"median":-2.469148,"eighty":-0.498339,"marketCap":9055781},{"date":"2025-05-09","current":-0.357914,"twenty":-11.74663,"median":-2.4399,"eighty":-0.484006,"marketCap":7749075},{"date":"2025-05-16","current":-0.318614,"twenty":-11.703806,"median":-2.379462,"eighty":-0.479331,"marketCap":6898196},{"date":"2025-05-23","current":-0.331126,"twenty":-11.703304,"median":-2.30379,"eighty":-0.471453,"marketCap":7169091},{"date":"2025-05-30","current":-0.312204,"twenty":-11.697333,"median":-2.247534,"eighty":-0.467602,"marketCap":6759428},{"date":"2025-06-06","current":-0.312204,"twenty":-11.665089,"median":-2.236297,"eighty":-0.464369,"marketCap":6759428},{"date":"2025-06-13","current":-0.316171,"twenty":-11.622097,"median":-2.159085,"eighty":-0.452748,"marketCap":6845307},{"date":"2025-06-20","current":-0.243086,"twenty":-11.583883,"median":-2.12392,"eighty":-0.449147,"marketCap":5262975},{"date":"2025-06-27","current":-0.222432,"twenty":-11.488345,"median":-2.028863,"eighty":-0.44634,"marketCap":4815794},{"date":"2025-07-03","current":-0.227198,"twenty":-11.478791,"median":-1.968872,"eighty":-0.439825,"marketCap":4918989},{"date":"2025-07-11","current":-0.31776,"twenty":-11.466849,"median":-1.934978,"eighty":-0.430622,"marketCap":6879706},{"date":"2025-07-18","current":-0.292339,"twenty":-11.426247,"median":-1.861254,"eighty":-0.417671,"marketCap":6329329},{"date":"2025-07-25","current":-0.316171,"twenty":-11.407139,"median":-1.841618,"eighty":-0.400052,"marketCap":6845307},{"date":"2025-08-01","current":-0.271684,"twenty":-11.40475,"median":-1.820549,"eighty":-0.396759,"marketCap":5882148},{"date":"2025-08-08","current":-0.230376,"twenty":-11.337874,"median":-1.797872,"eighty":-0.387497,"marketCap":4987786},{"date":"2025-08-15","current":-0.268507,"twenty":-11.292399,"median":-1.779196,"eighty":-0.360233,"marketCap":5813351},{"date":"2025-08-22","current":-0.279628,"twenty":-11.256644,"median":-1.76553,"eighty":-0.347235,"marketCap":6054141},{"date":"2025-08-29","current":-0.262152,"twenty":-11.230395,"median":-1.732843,"eighty":-0.342475,"marketCap":5675757},{"date":"2025-09-05","current":-0.266918,"twenty":-11.225618,"median":-1.721802,"eighty":-0.340117,"marketCap":5778953},{"date":"2025-09-12","current":-0.266918,"twenty":-11.153965,"median":-1.71087,"eighty":-0.331126,"marketCap":5778953},{"date":"2025-09-19","current":-0.262152,"twenty":-11.099032,"median":-1.699938,"eighty":-0.329629,"marketCap":5675757},{"date":"2025-09-26","current":-0.246264,"twenty":-11.094255,"median":-1.680747,"eighty":-0.327124,"marketCap":5331772},{"date":"2025-10-03","current":-0.353729,"twenty":-11.079924,"median":-1.669875,"eighty":-0.326496,"marketCap":6710638},{"date":"2025-10-10","current":-0.327847,"twenty":-11.07037,"median":-1.633897,"eighty":-0.327029,"marketCap":6219616},{"date":"2025-10-17","current":-0.402302,"twenty":-11.063205,"median":-1.615453,"eighty":-0.327124,"marketCap":7632122},{"date":"2025-10-24","current":-0.459366,"twenty":-11.051263,"median":-1.601549,"eighty":-0.327582,"marketCap":8714693},{"date":"2025-10-30","current":-0.416568,"twenty":-11.041709,"median":-1.579685,"eighty":-0.327897,"marketCap":7902765}],"updateTime":1761917417193},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYNZ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575778778","title":"Mainz Biomed NV to Attend Maxim Growth Summit in New York City","url":"https://stock-news.laohu8.com/highlight/detail?id=2575778778","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575778778?lang=en_us&edition=fundamental","pubTime":"2025-10-15 21:01","pubTimestamp":1760533287,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV, a molecular genetics diagnostic company specializing in early cancer detection, will attend the 2025 Maxim Growth Summit on October 22-23, 2025, at The Hard Rock Hotel NYC. The company will participate in one-on-one meetings with institutional investors and senior Maxim analysts during the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mainz Biomed NV published the original content used to generate this news brief via GlobeNewswire  on October 15, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nNDL2lS8p0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ","NDAQ","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4139","LU2095319765.USD","LU2210150020.SGD","BK4585","LU2210149790.SGD","IE00B64PRP62.GBP","BK4588","LU0314104364.USD","BK4112","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2573250289","title":"Mainz Biomed NV Reports Positive Results for BloodBased Pancreatic Cancer Screening Test in Feasibility Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2573250289","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573250289?lang=en_us&edition=fundamental","pubTime":"2025-10-08 21:00","pubTimestamp":1759928436,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV has announced positive topline results from a feasibility study evaluating a non-invasive blood-based screening test for the early detection of pancreatic cancer. The study assessed 18 proprietary mRNA biomarkers and identified a panel that demonstrated 100% sensitivity and 95% specificity in distinguishing pancreatic cancer patients from healthy controls within a 30-subject cohort. The results confirmed the clinical accuracy and utility of the biomarkers, and the company plans to initiate a larger clinical study using banked retrospective samples to further evaluate biomarker performance across different stages of pancreatic cancer. This future study will utilize next-generation sequencing technologies and is part of Mainz Biomed's broader strategy to develop accessible molecular diagnostics for early cancer detection.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and time","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nNDL1S70Qx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","MYNZ","BK4588","IE00B3QW5Z07.USD","BK4112","LU2095319765.USD","IE00B64PRP62.GBP","LU2210150020.SGD","NDAQ","LU0314104364.USD","LU2210149790.SGD","BK4585","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2572063611","title":"Mainz Biomed NV Enters Equity Distribution Agreement for Up to $10 Million in Ordinary Share Sales, Including $2.3 Million via Shelf Registration Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2572063611","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572063611?lang=en_us&edition=fundamental","pubTime":"2025-10-04 05:26","pubTimestamp":1759526786,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV Enters Equity Distribution Agreement for Up to $10 Million in Ordinary Share Sales, Including $2.3 Million via Shelf Registration Statement. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mainz Biomed NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL5WWplZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2571634291","title":"Mainz Biomed NV to Showcase Future of Colorectal Cancer Screening at World Endoscopy Organization Committee Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2571634291","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571634291?lang=en_us&edition=fundamental","pubTime":"2025-09-30 20:01","pubTimestamp":1759233690,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV, a diagnostics company specializing in early cancer detection, will participate in the upcoming plenary session of the World Endoscopy Organization  Committee for Colorectal Cancer Screening on October 3, 2025, in Berlin. At the event, Dr. Lena Krammes, Senior Scientist at Mainz Biomed, will present the company's latest findings on RNA-based diagnostics for the detection and prevention of precancerous lesions, comparing early evidence from their RNA-based screening test to various FIT  cut-offs.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDL5b8cWl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2570830092","title":"Mainz Biomed Reports Financial Results for First Half of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2570830092","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570830092?lang=en_us&edition=fundamental","pubTime":"2025-09-27 05:34","pubTimestamp":1758922492,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Mainz Biomed B.V. ( ($MYNZ) ). On September 26, 2025, Mainz Biomed N.V. released its Management’s Discussion an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-reports-financial-results-for-first-half-of-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-reports-financial-results-for-first-half-of-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2569909117","title":"Mainz Biomed announces commercial launch of ColoAlert in Switzerland","url":"https://stock-news.laohu8.com/highlight/detail?id=2569909117","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569909117?lang=en_us&edition=fundamental","pubTime":"2025-09-23 20:20","pubTimestamp":1758630027,"startTime":"0","endTime":"0","summary":"Mainz Biomed (MYNZ) announces the commercial launch of its flagship product, ColoAlert, in Switzerland. This milestone comes as the result of sever...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mainz-biomed-announces-commercial-launch-of-coloalert-in-switzerland-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mainz-biomed-announces-commercial-launch-of-coloalert-in-switzerland-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MYNZ"],"gpt_icon":0},{"id":"2569972547","title":"Mainz Biomed NV Announces Launch of ColoAlert® in Switzerland and Advances in eAArly DETECT 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2569972547","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569972547?lang=en_us&edition=fundamental","pubTime":"2025-09-23 20:01","pubTimestamp":1758628902,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV, a diagnostics company specializing in cancer early detection, has announced the commencement of the marketing of its primary product, ColoAlert, in Switzerland. This development marks a significant milestone following several key achievements by the company. Earlier this year, Mainz Biomed entered into a strategic partnership with labor team w ag, a leading diagnostics laboratory in Switzerland, to ensure the nationwide distribution of ColoAlert through an established and trusted network. The test has been officially registered and approved for distribution by Swissmedic, the Swiss agency for therapeutic products, enabling access to innovative colorectal cancer screening solutions for Swiss patients. In addition, a comprehensive technology transfer has been successfully completed, allowing the local processing and evaluation of ColoAlert samples in Goldach, Switzerland. Meanwhile, the company is advancing the recruitment for its feasibility study, which aims to include","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL2YvdJ3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2565568298","title":"Mainz Biomed NV  expected to post a loss of $2.80 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2565568298","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565568298?lang=en_us&edition=fundamental","pubTime":"2025-09-05 20:34","pubTimestamp":1757075644,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV  expected to post a loss of $2.80 a share - Earnings Preview Mainz Biomed NV MYNZ.OQ, MYNZ.O is expected to  report resultson September 8 for the period ending March 31 2025The Mainz H","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nL8N3US0OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ"],"gpt_icon":0},{"id":"2564253804","title":"Mainz Biomed Announces Regulatory Approval of ColoAlert for Distribution in the United Kingdom","url":"https://stock-news.laohu8.com/highlight/detail?id=2564253804","media":"Reuters","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564253804?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:02","pubTimestamp":1756814538,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV, a specialist in cancer early detection diagnostics, has announced that its ColoAlert test has received official registration from the Medicines and Healthcare products Regulatory Agency  in the United Kingdom. This milestone allows the test, which detects tumor DNA biomarkers in stool samples, to be distributed throughout the UK. This regulatory approval follows a technology partnership with EDX Medical Group plc and aims to complement existing colorectal cancer screening programs, enhancing accessibility and participation in early cancer detection efforts.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDL4gSrTR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2559604979","title":"Mainz Biomed NV Receives Swissmedic Approval for ColoAlert® Cancer Screening Test in Switzerland","url":"https://stock-news.laohu8.com/highlight/detail?id=2559604979","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559604979?lang=en_us&edition=fundamental","pubTime":"2025-08-13 20:03","pubTimestamp":1755086628,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV, a diagnostics company specializing in cancer early detection, has announced that its non-invasive colorectal cancer screening test, ColoAlert, has been officially registered and granted marketing approval by Swissmedic, the Swiss agency for therapeutic products. This approval allows ColoAlert to be marketed in Switzerland, following a partnership with the Swiss diagnostic laboratory, labor team w ag. The test, which detects colorectal cancer tumor DNA and other biomarkers in stool samples with high sensitivity, aims to improve early detection and increase participation in screening programs in Switzerland, where less than half of the eligible population currently participates in such programs. This milestone is part of Mainz Biomed's broader strategy to expand access to reliable colorectal cancer early detection solutions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL2XFlYt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2556338500","title":"Mainz Biomed Prices $3 million Follow-on Offering at $1.35 per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2556338500","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556338500?lang=en_us&edition=fundamental","pubTime":"2025-08-04 23:11","pubTimestamp":1754320289,"startTime":"0","endTime":"0","summary":"Mainz Biomed  said Monday it has priced a $3 million follow-on offering of 2.2 million units comprising shares and warrants at an offer price of $1.35 per unit.Each unit will comprise one share or a prefunded warrant and one Series A warrant for the purchase of one and one-half shares, the company said.The Series A warrants are immediately exercisable at $1.35 per share and will expire five years from the issue date, Mainz Biomed said.Price: 1.41, Change: +0.08, Percent Change: +6.02","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","MYNZ"],"gpt_icon":0},{"id":"2556380398","title":"Mainz Biomed NV Announces $3.0 Million Follow-On Offering of Ordinary Shares and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2556380398","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556380398?lang=en_us&edition=fundamental","pubTime":"2025-08-04 22:22","pubTimestamp":1754317358,"startTime":"0","endTime":"0","summary":"Mainz Biomed N.V., a molecular genetics diagnostic company focused on early cancer detection, announced the pricing of a $3.0 million follow-on offering. The offering includes 2,222,222 units, each comprising one ordinary share  and one Series A warrant to purchase one and a half ordinary shares. The units are priced at $1.35 each, with the Series A warrants exercisable at the same price, expiring five years from issuance. This offering is conducted under an SEC-approved registration statement, with Maxim Group LLC as the sole placement agent. The transaction is expected to close around August 5, 2025, subject to customary closing conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mainz Biomed NV published the original content ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDLnpXXQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU0314104364.USD","IE00BKPKM429.USD","NDAQ","BK4588","IE00B64PRP62.GBP","MYNZ","LU2210149790.SGD","BK4139","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","LU2095319765.USD","BK4112"],"gpt_icon":0},{"id":"2555027253","title":"Mainz Biomed NV Files For Offering 1.5 Million Ordinary Units - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2555027253","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555027253?lang=en_us&edition=fundamental","pubTime":"2025-07-31 05:38","pubTimestamp":1753911523,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV <4TO.F>::*MAINZ BIOMED NV FILES FOR OFFERING 1.5 MILLION ORDINARY UNITS - SEC FILING  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 30-JUL-202521:23:02 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nRSD5sfL0x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2553210945","title":"Mainz Biomed NV and CARE Partner to Enhance Colorectal Cancer Screening for German Health Insurers","url":"https://stock-news.laohu8.com/highlight/detail?id=2553210945","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553210945?lang=en_us&edition=fundamental","pubTime":"2025-07-23 20:01","pubTimestamp":1753272083,"startTime":"0","endTime":"0","summary":"Mainz Biomed N.V., a diagnostics company focused on early cancer detection, has announced a new collaboration with CARE diagnostica Laborreagenzien GmbH. This agreement will enhance colorectal cancer screening services by integrating Mainz Biomed's ColoAlert test into CARE's existing online-based screening concepts, which are already used by over 15 statutory health insurance companies in Germany. The ColoAlert test employs molecular genetic analysis of biomarkers in stool to improve detection rates, particularly in early stages. This cooperation aims to expand the distribution of ColoAlert in the German market, aligning with the increasing demand for personalized early intervention screening solutions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nNDL6BWz1P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BGHQF748.EUR","BK4112","LU2210150020.SGD","BK4585","NDAQ","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","MYNZ","IE00B64PRP62.GBP","BK4588","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2551162472","title":"Mainz Biomed NV Secures Government Funding for Innovative Pancreatic Cancer Screening Project from Rheinland-Pfalz Development Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2551162472","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551162472?lang=en_us&edition=fundamental","pubTime":"2025-07-15 20:02","pubTimestamp":1752580927,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV Secures Government Funding for Innovative Pancreatic Cancer Screening Project from Rheinland-Pfalz Development Bank. Mainz Biomed NV has announced that its pancreatic cancer project will receive public funding from the Investitions- und Strukturbank Rheinland-Pfalz , the development bank of the German federal state of Rheinland-Pfalz. Under the ISB's Innovation and Technology Support Program, the state will fund up to 50% of the project's total costs. This governmental support highlights the scientific and societal value of the company's non-invasive, blood-based screening test for early pancreatic cancer detection, and is expected to accelerate its development. The funding is specifically for Mainz Biomed, and there is no indication of multiple organizations receiving this grant.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDL1dCyMc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MYNZ"],"gpt_icon":0},{"id":"2551164423","title":"Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2551164423","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551164423?lang=en_us&edition=fundamental","pubTime":"2025-07-15 20:01","pubTimestamp":1752580860,"startTime":"0","endTime":"0","summary":"Company Advances its Progress toward FDA Premarket Approval Study for its Next Generation Colorectal Cancer Screening Product and Makes a Strategic Acquisition in theField of Pancreatic Cancer Screeni","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/15/3115553/0/en/Mainz-Biomed-Half-Year-2025-Update-Accelerating-FDA-Pathway-for-NextGen-Colorectal-Cancer-Screening-and-Expansion-with-Pancreatic-Cancer-Screening-Acquisition.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ","NGCAU"],"gpt_icon":0},{"id":"2546685217","title":"Press Release: Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2546685217","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546685217?lang=en_us&edition=fundamental","pubTime":"2025-06-25 20:01","pubTimestamp":1750852860,"startTime":"0","endTime":"0","summary":"BERKELEY, Calif. and MAINZ, Germany, June 25, 2025  -- Mainz Biomed N.V.  , a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to announce that its pancreatic cancer project will receive public funding from the Investitions- und Strukturbank Rheinland-Pfalz , the development bank of the German federal state of Rheinland-Pfalz.The award of the public grant underscores the medical and technological relevance of Mainz Biomed's approach. The project aims to close a critical gap in cancer diagnostics by detecting pancreatic cancer at an earlier, more treatable stage.\"This support from the ISB is a strong vote of confidence in the potential of our technology and the importance of early detection in combating pancreatic cancer,\" said Dr. Moritz Eidens, CSO of Mainz Biomed.The project is currently in the feasibility phase. Together with Crown Bioscience, Mainz Biomed is evaluating the performance of a panel of mRNA biomarkers and a ML-driven algor","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4232","R","BK4022","MYNZ"],"gpt_icon":0},{"id":"2541300675","title":"Mainz Biomed NV Board Meeting: Key Resolutions Include Amendment of Remuneration Policy and Auditor Assignments for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2541300675","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541300675?lang=en_us&edition=fundamental","pubTime":"2025-06-06 05:00","pubTimestamp":1749157257,"startTime":"0","endTime":"0","summary":"Mainz Biomed N.V., a public company under Dutch law, held its annual general meeting on June 2, 2025, at the CMS Derks Star Busman N.V. offices in Amsterdam. Chaired by non-executive director Hans Hekland, the meeting included the consideration of the statutory management report for the financial year ending December 31, 2024. All voting items on the agenda were adopted with the requisite majority. The meeting concluded with no further business. Documents related to the meeting, including the agenda with explanatory notes and a tabulation report by Broadridge, are available on the company's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mainz Biomed NV published the original content used to generate this news brief via EDGAR, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDLbCq0TD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1228905037.USD","BK4548","BK4106","LU0545562505.USD","LU1228905540.USD","BK4139","LU0390134368.USD","BR","IE0034235188.USD","MYNZ","BK4588","BK4585","BK4226","IE0009354923.USD"],"gpt_icon":0},{"id":"2537989894","title":"Will AI Empower the PR Industry or Create Endless Seas of Spam? -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2537989894","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537989894?lang=en_us&edition=fundamental","pubTime":"2025-05-21 18:00","pubTimestamp":1747821600,"startTime":"0","endTime":"0","summary":"Public-relations agencies email reporters every day with suggestions to cover their clients, but this pitch from March stood out from the flood with its unusual subject line: \"You care more about Tesla than a cancer killing thousands.\". The email went on to scold U.S.-based reporters for giving priority to Tesla earnings news and celebrity gossip over the work of Mainz Biomed, a German firm that develops tests for colorectal cancer.After rattling off statistics about increasing cancer rates, it stated, \"This isn't a future problem. It's happening right now. But you wouldn't know, because you've been covering crap that doesn't matter. Do better.\". This pitch was generated entirely by an artificial intelligence tool called PRAI, which suggested getting reporters' attention by combining the well-known Tesla name with a confrontational tone, according to Valentin Saitarli, who is chief executive of PRAI and managing director of Exclusive PR Solutions, a public relations firm that represent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU1267930573.SGD","PR","LU1914381329.SGD","LU2168564065.EUR","LU2275660780.HKD","BK4598","IE00BFSS7M15.SGD","LU0094547139.USD","LU1989772923.USD","IE00BJJMRY28.SGD","IE0004445239.USD","LU0868494617.USD","LU0266013472.USD","LU2491050071.SGD","LU1035773651.USD","LU0444973449.USD","LU0154236417.USD","MYNZ","LU2430703178.SGD","EMPW.U","IE0034235303.USD","LU2168564149.EUR","LU0095938881.EUR","LU2298321311.HKD","LU2362541273.HKD","LU2237443549.SGD","LU1064131342.USD","GB00BDT5M118.USD","LU0823421416.USD","LU1235295455.SGD","LU0345769128.USD","LU0029864427.USD","LU0097036916.USD","LU1720051108.HKD","BK4592","LU1261432733.SGD","LU2097829019.USD","LU2210149790.SGD","LU0312595415.SGD","LU2361044949.HKD","LU2077746001.SGD","SG9999018865.SGD","LU0061474705.USD","LU1670711040.USD","LU1496350171.SGD","LU2089284900.SGD","LU0234570918.USD","LU0061475181.USD"],"gpt_icon":1},{"id":"2536564736","title":"Mainz Biomed NV Announces $4.0 Million Follow-On Offering with New Warrants Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2536564736","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536564736?lang=en_us&edition=fundamental","pubTime":"2025-05-20 08:01","pubTimestamp":1747699290,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV, a molecular genetics diagnostic company, announced the pricing of a $4.0 million follow-on offering of 2,000,000 units, each consisting of an ordinary share and Series A and B warrants. The units are priced at $2.00 each. The Series A and B warrants are exercisable at $2.00 per share, with the Series A warrants expiring five years from issuance and Series B warrants expiring either 30 days after eAArly Detect 2 study results or one year from issuance. Additionally, a Warrant Amendment Agreement reduces the strike prices of previously issued warrants to $2.00. Maxim Group LLC is the sole placement agent, with the offering expected to close around May 21, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mainz Biomed ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL8s3Yw1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","MYNZ","LU2210150020.SGD","BK4585","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2095319765.USD","BK4139","IE00B64PRP62.GBP","BK4588","BK4112","IE00BKPKM429.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}